Connect with us
Everlasting Memorials

Uncategorized

When a breast cancer diagnosis knocked me down, a network of Jewish women lifted me up

(JTA) — On the way home from the hospital where I was given my diagnosis of grade 2 invasive lobular breast cancer, I directed my husband, through my tears, to stop at the kosher store.

“I don’t want to see anyone right now,” I said, knowing the inevitability of running into someone we knew in the small Jewish community where we live, “so can you go in?” He pulled into the parking lot. “We need challah,” I reminded him. It was Thursday, after all. The next evening was Shabbat. Time doesn’t stand still for cancer.

My hospital appointment took place two days after the front page of the New York Times declared: “When Should Women Get Regular Mammograms: At 40, U.S. Panel Now Says.” I was 48. Breast cancer has long been the second most common cancer for women, after skin cancer. It is also the most lethal after lung cancer. Statistically, though, most women affected are postmenopausal, so unless there was a specific reason to test early, women were screened regularly from the age of 50. Now, the advice has changed. Breast cancer is rising in younger women. For women in their 40s, the rate of increase between 2015 and 2019 doubled from the previous decade to 2 per cent per year.

Why is this happening? Air pollution? Microplastics? Chemicals in our food? We don’t know.

In the days following my appointment, there was a proliferation of articles about the topic. Importantly, doctors explained that the cancer women are diagnosed with in their 40s tends to be a more aggressive type of cancer. Cancers in premenopausal women grow faster; many breast cancers, like mine, are hormone sensitive. (Got estrogen? Bad luck for you.)

When I posted the news about my diagnosis — on Facebook, because I’m an oversharing type — I was stunned by the number of friends my age, more discreet about their lives, who sent me messages to tell me they had recently gone through the same thing. Everyone had advice. “If you can do a lumpectomy, you’re very lucky. It’s not a major operation, and you’ll preserve your breast.” “Cut it all off! Immediately! Just get rid of all it and you’ll never worry again! Do you want to spend the rest of your life in mammogram scanxiety?” “Ask plastic surgeons for pictures, and pick the cutest new boobs out there. You won’t regret it.” “The radiation burns—that’s something no one ever tells you. Get yourself some Lubriderm and lidocaine, mix into a slurry, slap it on a panty liner, and tuck it in your sports bra.”

I’m not sure why I thought I was immune. Or maybe I didn’t — maybe I just never gave it much thought. Even when I found the lump on my breast, I was dismissive. I went to the doctor, and she asked if anyone in my family had had breast cancer. “Oh, who knows? They were all murdered,” I said blithely. Her eyes bugged. “In the Holocaust,” I added. “Your…mother? Grandmother? Sisters?” “Oh! No, no history of breast cancer in my immediate family.”

Add to that, my mother and sister both tested negative for the BRCA gene mutations, and that’s my Ashkenazi side. The thing is, though, most women who test positive for breast cancer have no family history of it.

But also, I’d done everything right! If you look through the preventative measures, I took all of them. I had three kids by 35, and I breastfed them. I have a healthy, mostly plant-based diet; I walk and cycle everywhere. I’m not a drinker or smoker. I eat so many blueberries!

Several of the articles that have been published in recent days are emphasizing the particular danger for Black women, with good reason: They have twice the mortality rate of white women. But as I did my research, I realized that Jewish women should also be on high alert. We’ve long known that one in forty Ashkenazi women has the BRCA gene mutation, significantly raising the risk of breast cancer (50% of women with the gene mutation will get breast cancer) as well ovarian cancer, which is much harder to detect and far more deadly. So many of my friends who reached out to me to tell me of their breast cancer experiences are Jewish; interestingly, not one has the BRCA mutation. Are these high numbers indicative or anecdotal? Are Jewish women generally more susceptible to breast cancer? This seems to be an important area of future research.

For me, that research will come too late — as did the guidance. For now, I have to accept that this cancer diagnosis is part of my life, that just as I will pick up challah every Thursday, I will wake every morning and take my hormone-blocking Tamoxifen. I will lose sleep every night about which surgery to have until I have the surgery, and then I will lose sleep every night about whether it was fully successful. And there’s plenty more in store for me that isn’t pretty; so it goes.

But here’s a good thing that’s already come out of this diagnosis: When the responses to my Facebook post flooded in, they were not only along the lines of “Refuah shleimah” and “I’ve just been through this too,” but also, “Thank you for sharing! I’m going to book my mammogram right now!”


The post When a breast cancer diagnosis knocked me down, a network of Jewish women lifted me up appeared first on Jewish Telegraphic Agency.

Continue Reading

Uncategorized

A quiet diplomatic shift in the Middle East, with monumental consequences for Israel

Something significant is happening between Israel and Syria, and it deserves more attention than it is getting.

With the backing of the United States, Israeli and Syrian officials have agreed to create what they call a “joint fusion mechanism” — a permanent channel for coordination on intelligence, de-escalation, diplomacy and economic matters — during meetings in Paris. It appears to be the beginning of institutionalized contact between two countries that have formally been at war since 1948.

If this process continues, it will count as a genuine foreign-policy success for President Donald Trump’s administration.

To understand how profound that change would be, it is worth recalling the two countries’ shared history.

Israel and Syria — which the U.S. struck with a set of targeted attacks on the Islamic State on Saturday — have fought openly or by proxy for decades. Before 1967, Syrian artillery positions in the Golan Heights regularly shelled Israeli communities in the Hula Valley and around the Sea of Galilee. After Israel captured that region in 1967, the direct shelling stopped, but the conflict did not.

Syria remained formally committed to a state of war; Israel entrenched itself in the Golan Heights; both sides treated the frontier as a potential flashpoint to be managed carefully. After Egypt and Israel made peace in 1979, Syria became Israel’s most dangerous neighboring state.

A 1974 disengagement agreement created a United Nations-monitored buffer zone, which mostly ensured peace along the border, but did not resolve anything fundamental. In Lebanon, Israel and Syria backed opposing forces for years, and their air forces clashed briefly during the 1982 Lebanon War. Later, Iran’s growing role in Syria and Hezbollah’s military buildup added new threats. The Syrian civil war then destroyed basic state capacity and created precisely the kind of militia-rich environment Israel fears along its borders.

Now, with the dictator Bashar al-Assad gone and the former rebel leader Ahmed al-Sharaa in power, Syria is a broken country trying to stabilize. Sharaa’s past associations, disturbingly, include leadership of jihadist groups that were part of the wartime landscape in Syria. But today he governs a state facing economic collapse, infrastructure ruin and a population that needs jobs and basic services. His incentives are simple and powerful: ensure the survival of his regime, invite foreign investment, and secure relief from isolation and sanctions. Those goals point toward the U.S. and its partners, including Israel.

The Trump administration has made it clear that it wants to see new Syrian cooperation with Israel, with the suggestion that progress with Israel will become a gateway to international investment, and to a degree of political acceptance that Syria has lacked for years. Al-Sharaa’s willingness to engage is therefore not a mystery.

Israel’s motivations are also straightforward. After the Gaza war, Israel is facing a severe reputational problem. It is widely viewed abroad as reckless and excessively militarized. The government is under pressure over not only the conduct of the war but also the perception that it has no political strategy and relies almost exclusively on force. A diplomatic track with Syria allows Israel to present a very different picture: that of a country capable of negotiations with ideologically opposed neighbors, de-escalation, and regional cooperation.

There are significant security incentives, too.

Israel wants to limit Iran and Hezbollah’s influence in Syria. It wants a predictable northern border. It wants assurances regarding the Druze population in southern Syria — brethren to the Israeli Druze who are extremely loyal to the state, and who were outraged after a massacre of Syrian Druze followed the installation of al-Sharaa’s regime. It wants to ensure that no armed Syrian groups will tread near the Golan. A coordinated mechanism supervised by the U.S. offers a strong diplomatic way to address these issues.

The U.S. will benefit as well. The Trump team is eager to show that it can deliver lasting diplomatic achievements in the Middle East after the success of the Abraham Accords in Trump’s first term. A meaningful shift in Israel–Syria relations would be a very welcome addition, especially as the U.S.-brokered ceasefire in the Gaza war faces an uncertain future.

The main questions now are practical. Can the “joint fusion mechanism” function under pressure? What will happen when there is, almost inevitably, an incident — a drone downed, a militia clash, a cross-border strike? Will the new system effectively lower the temperature, or will it collapse at the first crisis?

Will Iran — facing its own profound internal political crisis — accept a Syria that coordinates with Israel under U.S. supervision, or will it work to undermine al-Sharaa? How will Hezbollah react if Damascus appears to move away from the axis of “resistance” and toward a security understanding with Israel?

How would an Israel-Syria deal impact Lebanon’s moribund efforts to dismantle Hezbollah’s military capacity? Al-Sharaa has already helped significantly by ending the transfer of weapons to Hezbollah from Iran through his territory. Might he also actively help with the disarming of the group?

No one should expect a full peace treaty soon. The question of possession of the Golan Heights probably remains a deal-breaker. Public opinion in Syria has been shaped by decades of official hostility to Israel, and Israeli politics is fragmented and volatile.

But diplomatic breakthroughs can confound expectations. They usually begin with mechanisms like this one, involving limited cooperation, routine contact and crisis management.

If this effort helps move the border from a zone of permanent tension to one of managed stability, that alone would be a major shift. It would also send a signal beyond the region: U.S. engagement still matters, and American pressure and incentives can still change behavior.

The post A quiet diplomatic shift in the Middle East, with monumental consequences for Israel appeared first on The Forward.

Continue Reading

Uncategorized

Israel’s Netanyahu Hopes to ‘Taper’ Israel Off US Military Aid in Next Decade

Israeli Prime Minister Benjamin Netanyahu speaks to the press on Capitol Hill, Washington, DC, July 8, 2025. REUTERS/Evelyn Hockstein

Israeli Prime Minister Benjamin Netanyahu said in an interview published on Friday that he hopes to “taper off” Israeli dependence on US military aid in the next decade.

Netanyahu has said Israel should not be reliant on foreign military aid but has stopped short of declaring a firm timeline for when Israel would be fully independent from Washington.

“I want to taper off the military within the next 10 years,” Netanyahu told The Economist. Asked if that meant a tapering “down to zero,” he said: “Yes.”

Netanyahu said he told President Donald Trump during a recent visit that Israel “very deeply” appreciates “the military aid that America has given us over the years, but here too we’ve come of age and we’ve developed incredible capacities.”

In December, Netanyahu said Israel would spend 350 billion shekels ($110 billion) on developing an independent arms industry to reduce dependency on other countries.

In 2016, the US and Israeli governments signed a memorandum of understanding for the 10 years through September 2028 that provides $38 billion in military aid, $33 billion in grants to buy military equipment and $5 billion for missile defense systems.

Israeli defense exports rose 13 percent last year, with major contracts signed for Israeli defense technology including its advanced multi-layered aerial defense systems.

US Republican Senator Lindsey Graham, a staunch Israel supporter and close ally of Trump, said on X that “we need not wait ten years” to begin scaling back military aid to Israel.

“The billions in taxpayer dollars that would be saved by expediting the termination of military aid to Israel will and should be plowed back into the US military,” Graham said. “I will be presenting a proposal to Israel and the Trump administration to dramatically expedite the timetable.”

Continue Reading

Uncategorized

In Rare Messages from Iran, Protesters ask West for Help, Speak of ‘Very High’ Death Toll

Protests in Tehran. Photo: Iran Photo from social media used in accordance with Clause 27a of the Copyright Law, via i24 News

i24 NewsSpeaking to Western media from beyond the nationwide internet blackout imposed by the Islamic regime, Iranian protesters said they needed support amid a brutal crackdown.

“We’re standing up for a revolution, but we need help. Snipers have been stationed behind the Tajrish Arg area [a neighborhood in Tehran],” said a protester in Tehran speaking to the Guardian on the condition of anonymity. He added that “We saw hundreds of bodies.”

Another activist in Tehran spoke of witnessing security forces firing live ammunition at protesters resulting in a “very high” number killed.

On Friday, TIME magazine cited a Tehran doctor speaking on condition of anonymity that just six hospitals in the capital recorded at least 217 killed protesters, “most by live ammunition.”

Speaking to Reuters on Saturday, Setare Ghorbani, a French-Iranian national living in the suburbs of Paris, said that she became ill from worry for her friends inside Iran. She read out one of her friends’ last messages before losing contact: “I saw two government agents and they grabbed people, they fought so much, and I don’t know if they died or not.”

Continue Reading

Copyright © 2017 - 2023 Jewish Post & News